| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11886-008-0030-4 |
| P698 | PubMed publication ID | 18489859 |
| P2093 | author name string | JoAnn Lindenfeld | |
| Joseph Cleveland | |||
| Andreas Brieke | |||
| P2860 | cites work | Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q22306347 |
| Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction | Q28208692 | ||
| Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial | Q28241346 | ||
| Use of a continuous-flow device in patients awaiting heart transplantation | Q28244009 | ||
| Combination of isosorbide dinitrate and hydralazine in blacks with heart failure | Q28292266 | ||
| A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure | Q28328342 | ||
| The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
| Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. | Q31383623 | ||
| Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group | Q33157410 | ||
| A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database | Q33291493 | ||
| Effect of carvedilol on survival in severe chronic heart failure | Q33949292 | ||
| Long-term use of a left ventricular assist device for end-stage heart failure. | Q34109624 | ||
| Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction | Q34187441 | ||
| Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure | Q34321811 | ||
| Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure | Q34386004 | ||
| Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics | Q34693437 | ||
| Initial experience with the AbioCor implantable replacement heart system | Q35643383 | ||
| Basic principles of the intraaortic balloon pump and mechanisms affecting its performance | Q36169621 | ||
| LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery | Q36453687 | ||
| Correlation between negative near-wall shear stress in human aorta and various stages of congestive heart failure | Q39651791 | ||
| Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience | Q40513058 | ||
| The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group | Q42556789 | ||
| Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. | Q42688791 | ||
| The Heartmate III: design and in vivo studies of a maglev centrifugal left ventricular assist device | Q43638142 | ||
| Results from late-breaking clinical trial sessions at the American College of Cardiology 51st Annual Scientific Session | Q44060902 | ||
| Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial | Q44994661 | ||
| Single-center experience with the thoratec ventricular assist device | Q45055088 | ||
| Continuous aortic flow augmentation: a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure. | Q46795009 | ||
| Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation | Q47630614 | ||
| Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu | Q47849023 | ||
| Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). | Q47945239 | ||
| Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report--2005. | Q50768809 | ||
| Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. | Q50954069 | ||
| Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. | Q51010198 | ||
| Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support. | Q51135260 | ||
| Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. | Q51241307 | ||
| Left ventricular assist device-related infection: treatment and outcome. | Q51521286 | ||
| Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. | Q51535796 | ||
| Cardiac replacement with a total artificial heart as a bridge to transplantation. | Q51627532 | ||
| Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection. | Q51722025 | ||
| Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? | Q59356509 | ||
| Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group | Q68426735 | ||
| Duration of left ventricular assist device support affects transplant survival | Q71861935 | ||
| Improved Mortality and Rehabilitation of Transplant Candidates Treated with a Long-Term Implantable Left Ventricular Assist System | Q72065584 | ||
| Selection criteria for placement of left ventricular assist devices | Q72400492 | ||
| Revised screening scale to predict survival after insertion of a left ventricular assist device | Q73276780 | ||
| Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion | Q73315655 | ||
| The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device | Q73408439 | ||
| The influence of infection on survival and successful transplantation in patients with left ventricular assist devices | Q73673433 | ||
| Hemodynamic unloading of the failing left ventricle using an arterial-to-arterial extracorporeal flow circuit | Q75271547 | ||
| The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry | Q77111563 | ||
| Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance | Q77337425 | ||
| Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients | Q78299182 | ||
| P433 | issue | 3 | |
| P921 | main subject | heart failure | Q181754 |
| chronic heart failure | Q11829287 | ||
| P304 | page(s) | 168-175 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | Current cardiology reports | Q26842345 |
| P1476 | title | Mechanical support in acute and chronic heart failure | |
| P478 | volume | 10 |
| Q37759964 | ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference | cites work | P2860 |
Search more.